Influenza Vaccine Market Statistics, Size Will Hit $10,127.0 Million By 2030 | New Report

Influenza Vaccine Market Statistics 

• Influenza Vaccine Market Expected to Reach $10,127.0 Million by 2030.
• Influenza Vaccine Market registering a CAGR of 7.20% from 2021 to 2030.
• The Quadrivalent segment contributing to more than three-fifths of the total share, and is expected to maintain the lead throughout the forecast period.
•  North America is expected to provide lucrative market growth opportunities and grow at a CAGR of 6.9% from 2021 to 2030.
• The injection segment expected to grow at a CAGR of 7.40% from 2021 to 2030.
• The Adult segment is expected to remain dominant throughout the forecast period.
• The egg based segment expected to grow at a CAGR of 7.70% from 2021 to 2030.

Request Sample of the Report: 

https://www.alliedmarketresearch.com/request-sample/1437

Increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines drive the growth of the influenza vaccine market.

According to the report published by Allied Market Research, the global Influenza Vaccine Market generated $5.02 billion in 2020, and is projected to reach $10.12 billion by 2030, registering a CAGR of 7.2% from 2021 to 2030. In-depth information about restraints, key drivers, opportunities, and their impact analysis on the market is offered in the report.

Factors affecting the growth of the Influenza Vaccine Market:

Epidemiological Trends

• Seasonal Outbreaks: The annual variation in influenza strains and the severity of seasonal outbreaks significantly drive the demand for vaccines.
• Pandemic Threats: The occurrence of pandemics, like the H1N1 influenza in 2009, spikes demand for vaccines due to heightened awareness and urgent need.

Public Health Policies and Government Initiatives

• Vaccination Programs: Government-funded vaccination programs and campaigns aimed at increasing vaccination coverage, especially among vulnerable populations such as the elderly, children, and healthcare workers.
• Funding and Subsidies: Increased funding and subsidies for vaccine research, development, and distribution by governments and international organizations.

Technological Advancements

• Vaccine Development: Innovations in vaccine technology, such as the development of cell-based and recombinant vaccines, which can be produced more quickly and are more adaptable to different strains.
• Delivery Methods: Advances in delivery methods, including needle-free systems and intradermal shots, which can improve vaccine acceptance and compliance.

Healthcare Infrastructure

• Distribution Channels: The efficiency and reach of vaccine distribution networks, especially in rural and underserved areas, impact market growth.
• Cold Chain Logistics: The availability of robust cold chain logistics to maintain vaccine efficacy from production to administration.

Drive Your Business Growth Strategy: Purchase the Report for Key Insights

Market Segmentation:

By Vaccine Type

• Quadrivalent
• Trivalent

By Type

• Seasonal
• Pandemic

By Technology

• Egg-based
• Cell-based

By Age Group

• Pediatric
• Adult

By Route Of Administration

• Injection
• Nasal Spray

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America was the highest revenue contributor in the global influenza vaccine market and accounted for a 47.80% share in 2020. On the other hand, Middle East and Africa is expected to grow at a CAGR of 8.0%, owing to rise in incidences of influenza among children and increase in disposable income.

Leading Market Players: 

• Biodiem
• Sanofi Pasteur SA
• AstraZeneca plc.
• F. Hoffmann-La Roche Ltd.
• Emergent BioSolutions
• GlaxoSmithKline plc
• Gamma Vaccines Pty Ltd.
• Merck & Co. Inc. (Merck Sharp & Dohme Corp.)
• Novartis AG
• CSL Limited
• Pfizer, Inc.
• Sinovac Biotech Ltd.

Want to Explore More, Connect to our Analyst- 

https://www.alliedmarketresearch.com/connect-to-analyst/1437

Other Trending Reports in Life Science Domain- 

Chlorpheniramine Maleate Market:

https://www.alliedmarketresearch.com/chlorpheniramine-maleate-market

Penicillin Drug Market:

https://www.alliedmarketresearch.com/penicillin-drug-market-A110795

Radiology Information System Market:

https://www.alliedmarketresearch.com/radiology-information-systems-market

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact Us:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com